Causes and Management of Bubonic Plague
Causative Agent and Transmission
Bubonic plague is caused by Yersinia pestis, a gram-negative coccobacillus transmitted primarily through bites from infected fleas (especially Xenopsylla cheopis) or direct contact with infected animal tissues. 1 The bacteria persist in nature through rodent-flea cycles, with sporadic outbreaks spilling over to humans 1, 2.
Transmission Routes:
- Flea bites (most common for bubonic form)
- Direct contact with infected rodent tissues or fluids
- Inhalation of respiratory droplets (leads to pneumonic plague)
- Contaminated food consumption 3
Clinical Presentation
Following a flea bite, Y. pestis enters through the skin and is transported via lymphatics to regional lymph nodes, where it multiplies and produces the characteristic tender swelling called a "bubo" 1.
Key symptoms develop 2-8 days after infection:
- Painful, swollen lymph nodes (buboes) - the hallmark finding
- High fever and chills
- Malaise and headache
- Without treatment, progression to septicemic or pneumonic plague occurs 1
The untreated fatality rate is 66%, but drops dramatically to 13% with appropriate antimicrobial therapy 1.
Management: First-Line Treatment
For Bubonic Plague, initiate treatment immediately with fluoroquinolones or aminoglycosides for 10-14 days 1:
Preferred First-Line Agents:
- Ciprofloxacin: 400 mg IV every 8 hours OR 500 mg PO every 8 hours 1
- Levofloxacin: 750 mg IV or PO every 24 hours 1
- Gentamicin: 5 mg/kg IV or IM every 24 hours 1
This represents a significant update from older guidelines - ciprofloxacin has been elevated from alternative to first-line status based on accumulating clinical evidence 1. The 2021 CDC guidelines simplified treatment recommendations away from the previous "contained casualty vs. mass casualty" framework, providing greater flexibility to use oral agents early for mild-to-moderate illness 1.
Alternative Agents:
- Moxifloxacin: 400 mg IV or PO every 24 hours
- Streptomycin: 1 g IV or IM every 12 hours (historically considered gold standard but less preferred now)
- Doxycycline: 200 mg loading dose, then 100 mg every 12 hours
- Trimethoprim-sulfamethoxazole: 5 mg/kg (trimethoprim component) every 8 hours 1
Special Populations
Pregnant Women:
Gentamicin is strongly preferred over streptomycin due to lower risk of irreversible fetal ototoxicity 1. Fluoroquinolones (ciprofloxacin, levofloxacin) are also first-line options, as recent safety reviews found no association with pregnancy loss or birth defects 1. The critical principle: the severe risks of untreated plague far outweigh theoretical antimicrobial risks during pregnancy.
Children:
Use weight-based dosing of the same first-line agents. Children may be at higher risk following bioterrorism attacks due to increased respiratory rates and proximity to ground surfaces 1.
Critical Clinical Pitfalls
Delayed treatment is lethal: Bubonic plague can rapidly progress to septicemic or secondary pneumonic forms if treatment is delayed. Start empiric therapy immediately upon clinical suspicion - do not wait for laboratory confirmation 1.
Monitor for progression: Even with treatment, hematogenous spread can cause secondary complications including pneumonic plague (nearly 100% fatal if untreated) or meningeal plague 1.
Dual therapy consideration: The 2021 guidelines recommend dual therapy with distinct antimicrobial classes for pregnant women, which may be prudent for severe cases in any population 1.
IV access initially preferred: While oral therapy is acceptable for mild-to-moderate disease, parenteral administration is preferred initially when feasible 1.
Diagnostic Confirmation
Diagnosis is confirmed through standard bacteriological techniques (Gram stain, culture), serology, rapid diagnostic tests, or PCR 2. However, treatment must begin on clinical suspicion alone - the 2-8 day incubation period and rapid progression demand immediate action 1.
Public Health Context
Plague remains endemic in Madagascar, Democratic Republic of Congo, and Peru, with Madagascar experiencing the largest 21st-century epidemic in 2017 (>2000 cases, 200 deaths) 2. The disease is also recognized as a potential bioterrorism agent, making clinical familiarity essential 1, 4.
Human-to-human transmission is rare in bubonic plague but can occur with pneumonic forms through respiratory droplets 3, 5. Isolation precautions should be implemented for suspected pneumonic cases.